Alogliptin, a potent and selective ... [Curr Opin Investig Drugs. 2008] - PubMed

loading

Review Alogliptin for the treatment of type 2 diabetes. [Drugs Today (Barc). 2011]
Review Alogliptin for the treatment of type 2 diabetes.
White JR. Drugs Today (Barc). 2011 Feb; 47(2):99-107.
Review Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. [Expert Opin Pharmacother. 2009]
Review Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.
Pratley RE. Expert Opin Pharmacother. 2009 Feb; 10(3):503-12.
Review Alogliptin: a review of its use in the management of type 2 diabetes mellitus. [Drugs. 2010]
Review Alogliptin: a review of its use in the management of type 2 diabetes mellitus.
Scott LJ. Drugs. 2010 Oct 22; 70(15):2051-72.
Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies. [J Am Geriatr Soc. 2009]
Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies.
Pratley RE, McCall T, Fleck PR, Wilson CA, Mekki Q. J Am Geriatr Soc. 2009 Nov; 57(11):2011-9. Epub 2009 Sep 30.
A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure. [Life Sci. 2009]
A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure.
Asakawa T, Moritoh Y, Kataoka O, Suzuki N, Takeuchi K, Odaka H. Life Sci. 2009 Jul 17; 85(3-4):122-6. Epub 2009 May 8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the tre...
Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes.
Curr Opin Investig Drugs. 2008 Apr ;9(4):402-13.

PubMed
Development of a polymerase chain reaction assay for specific identification of ...
Development of a polymerase chain reaction assay for specific identification of Clostridium colinum.
Avian Pathol. 2008 Apr ;37(2):179-81.

PubMed
A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides....
A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
Int J Rad Appl Instrum B. 1991 ;18(8):871-81.

PubMed
Outcome of emergency caesarean sections in Calabar, Nigeria: Impact of the senio...
Outcome of emergency caesarean sections in Calabar, Nigeria: Impact of the seniority of the medical team.
J Obstet Gynaecol. 2008 Feb ;28(2):198-201.

PubMed
Minimization of the Escherichia coli genome using the Tn5-targeted Cre/loxP exci...
Minimization of the Escherichia coli genome using the Tn5-targeted Cre/loxP excision system.
Methods Mol Biol. 2008 ;416:261-77.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed